Literature DB >> 27510309

Genotype-phenotype correlation of SMN locus genes in spinal muscular atrophy children from Argentina.

Sofía Medrano1, Soledad Monges2, Luis Pablo Gravina1, Laura Alías3, Julieta Mozzoni4, Hilda Verónica Aráoz1, Sara Bernal3, Angélica Moresco5, Lilien Chertkoff1, Eduardo Tizzano6.   

Abstract

BACKGROUND/
PURPOSE: Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder, considered one of the leading causes of infant mortality. It is caused by mutations in the SMN1 gene. A highly homologous copy of this gene named SMN2 and other neighbouring genes, SERF1A and NAIP, are considered phenotypic modifiers of the disease. In recent years, notable advances have been made in SMA research regarding evaluation, prognosis, and therapeutic options. Thus, genotype-phenotype studies in SMA are important to stratify patients for motor function tests and for envisaged clinical trials. The aim of this study was to provide clinical and molecular data of a series of Argentinean children with SMA to establish a comprehensive genotype-phenotype correlation.
METHODS: 144 Argentinean children with SMA (56 children with type I, 58 with type II, and 30 with type III) were evaluated. The copy number of SMN2, SERF1A, and NAIP genes was established using MLPA (Multiplex Ligation-dependent Probe Amplification) and then correlated with the patients clinical subtypes. To improve clinical characterization we considered the initial symptoms that prompted the consultation, age of acquisition of motor abilities to independent walking and age at loss of gait. We also evaluated clinical and molecular features of sibling pairs in seven families.
RESULTS: A strong correlation was observed between the SMN2 copy number and SMA phenotype while SERF1A and NAIP copy number showed a moderate correlation. We observed intra- and inter-family differences among the SMA types.
CONCLUSION: This first genotype-phenotype correlation study in Argentinean SMA children provides data to improve patient stratification and define more adequate follow-up parameters.
Copyright © 2016 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Multiplex Ligation-dependent Probe Amplification (MLPA); Neuronal apoptosis inhibitory protein gene (NAIP); Small EDRK-rich factor 1A (SERF1A); Spinal muscular atrophy (SMA); Survival motor neuron 1 gene (SMN1); Survival motor neuron 2 gene (SMN2)

Mesh:

Substances:

Year:  2016        PMID: 27510309     DOI: 10.1016/j.ejpn.2016.07.017

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  4 in total

1.  Spinal Muscular Atrophy (SMA) Subtype Concordance in Siblings: Findings From the Cure SMA Cohort.

Authors:  Cynthia C Jones; Suzanne F Cook; Jill Jarecki; Lisa Belter; Sandra P Reyna; John Staropoli; Wildon Farwell; Kenneth Hobby
Journal:  J Neuromuscul Dis       Date:  2020

2.  Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy.

Authors:  Anna Lusakowska; Maria Jedrzejowska; Anna Kaminska; Katarzyna Janiszewska; Przemysław Grochowski; Janusz Zimowski; Janusz Sierdzinski; Anna Kostera-Pruszczyk
Journal:  Orphanet J Rare Dis       Date:  2021-03-24       Impact factor: 4.123

3.  Autopsy of a child with Spinal muscular atrophy Type I (Werdnig-Hoffmann disease).

Authors:  Manoj Gopal Madakshira; Sonal Singla; Kirti Gupta; Sayeeda Zahan; Pradip Paria; Jitendra Kumar Sahu
Journal:  Autops Case Rep       Date:  2020-04-23

4.  Investigation on the Effects of Modifying Genes on the Spinal Muscular Atrophy Phenotype.

Authors:  Drenushe Zhuri; Hakan Gurkan; Damla Eker; Yasemin Karal; Sinem Yalcintepe; Engin Atli; Selma Demir; Emine Ikbal Atli
Journal:  Glob Med Genet       Date:  2022-09-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.